iTeos Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ITOS and other ETFs, options, and stocks.

About ITOS

iTeos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of a new generation of immuno-oncology therapeutics for people living with cancer. Its pipeline includes EOS-448, Inupadenant, and EOS-984.

CEO

Michel Detheux

CEOMichel Detheux

Employees

173

Employees173

Headquarters

Watertown, Massachusetts

HeadquartersWatertown, Massachusetts

Founded

2012

Founded2012

Employees

173

Employees173

ITOS Key Statistics

Market cap

332.98M

Market cap332.98M

Price-Earnings ratio

-2.69

Price-Earnings ratio-2.69

Dividend yield

—

Dividend yield—

Average volume

3.03M

Average volume3.03M

High today

$8.75

High today$8.75

Low today

$8.13

Low today$8.13

Open price

$8.21

Open price$8.21

Volume

1.90M

Volume1.90M

52 Week high

$18.13

52 Week high$18.13

52 Week low

$4.80

52 Week low$4.80

Analyst ratings

50%

of 6 ratings

Buy

50%

Hold

50%

Sell

People also own

Based on the portfolios of people who own ITOS. This list is generated using Robinhood data, and it’s not a recommendation.